Different signals, related biology
GLP-1 and GIP are incretin hormones involved in the response to nutrients. Glucagon is a separate hormone with important roles in glucose regulation and energy metabolism. Medicines and investigational compounds may act on one, two, or three receptor systems, but receptor count is not a ranking of overall clinical value.
Compare the right products
Semaglutide and tirzepatide have distinct molecular designs, labeled indications, and product formulations. Some other multi-receptor agonists remain under investigation. A result for one product does not establish the effectiveness of another product sold under a similar name.
Why cross-trial comparisons mislead
Studies differ in participant characteristics, background care, dose escalation, duration, treatment discontinuation, and the way outcomes are analyzed. Head-to-head trials can improve comparability but still have limits. Report the trial context alongside any number, including whether the participants had diabetes.
Personal decisions need personal context
A clinician considers medical history, concomitant medicines, contraindications, response, and tolerability. The strongest result in an average study population does not establish the right choice for every individual. Use official labeling for current product details.